I
BBIO icon

InceptionR’s BridgeBio Pharma BBIO Stock Holding History

InceptionR’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Sell
6,791
-2,013
-23% -$141K 0.12% 306
2026
Q1 		$654K Buy
8,804
+2,809
+47% +$204K 0.16% 227
2025
Q4 		$459K Buy
5,995
+723
+14% +$47.5K 0.13% 304
2025
Q3 		$274K Buy
+5,272
New +$257K 0.07% 493

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

InceptionR's BBIO Position: Q2 2026 in Review

InceptionR reduced its BridgeBio Pharma (BBIO) stake by 23% in Q2 2026, selling an estimated $141K and leaving 6,791 shares worth $506K. The position accounts for 0.12% of the portfolio, ranked #306.

InceptionR first reported a position in BBIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $654K in Q1 2026. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • InceptionR held 6,791 shares of BridgeBio Pharma worth $506K as of Q2 2026.
  • InceptionR sold 2,013 BridgeBio Pharma shares in Q2 2026, an estimated $141K.
  • BridgeBio Pharma made up 0.12% of InceptionR's portfolio in Q2 2026, its #306 holding.
  • InceptionR first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 4 quarters since.
  • InceptionR's BridgeBio Pharma position peaked at $654K in Q1 2026.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.